Reported Aug 14, 2013 · Terminated

MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca…

AstraZeneca Pharmaceuticals LP

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: AstraZeneca Pharmaceuticals LP · 1800 Concord Pike · Wilmington, DE · 19850

Is this the product you have?

  • MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only
  • Mfd forAstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30
Lot codes and dates
    • NDC 0310-321-30
    • lot JX109
    • expiration 2/2015
    • lot JY042
    • expiration 2/2015
Amount recalled
81,900 total vials

Where it was sold

Why it was recalled

Presence of Precipitate; potential for incomplete constitution upon addition of diluent.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new AstraZeneca Pharmaceuticals LP recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jan 29, 2015 · Data as of Sep 19, 7:19 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.